Allergy Relief
- Product NDC
- 59726-701
- 11-digit product format
- 597260701
- Labeler code
- 59726
- Product ID
- 59726-701_20021f32-e254-4422-a17c-48c3b8704008
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Fexofenadine HCl
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- P & L Development, LLC
- Application
- ANDA204507
- Marketing category
- ANDA
- Marketing start
- 2021-08-20
- Substance
- FEXOFENADINE HYDROCHLORIDE
- Active strength
- 180 mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Allergy Relief
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FEXOFENADINE HYDROCHLORIDE | 180 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2S068B75ZU |
| Rxcui | 997420 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59726-701-15 | Allergy Relief | 1 in 1 BOX | TABLET, COATED | 1 | | 8 |
| 59726-701-15 | Allergy Relief | 150 in 1 BOTTLE, PLASTIC | TABLET, COATED | 150 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59726-701 | ALLERGY RELIEF (FEXOFENADINE HCL) TABLET, COATED [P & L DEVELOPMENT, LLC] | 8 | Current NDC, Legacy NDC, 2 package rows | 20240912_35b807b5-2e7a-446b-b378-eb5391ddfd14.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59726-701-15 | 59726070115 | 1 BOTTLE, PLASTIC in 1 BOX (59726-701-15) / 150 TABLET, COATED in 1 BOTTLE, PLASTIC | 2021-08-20 | 0000-00-00 | No | No | Current |